X-ray and cryo-EM structures of inhibitor-bound cytochrome bc 1 complexes for structure-based drug discovery

Structures of inhibitor-bound bovine cytochrome bc 1 were determined by cryo-EM and compared with X-ray crystallographic structures, demonstrating that cryo-EM could be a feasible tool for structure-based drug discovery.

[1]  N. Pannu,et al.  REFMAC5 for the refinement of macromolecular crystal structures , 2011, Acta crystallographica. Section D, Biological crystallography.

[2]  Joanne M. Morrisey,et al.  Resistance mutations reveal the atovaquone‐binding domain of cytochrome b in malaria parasites , 1999, Molecular microbiology.

[3]  J Koepke,et al.  Structure at 2.3 A resolution of the cytochrome bc(1) complex from the yeast Saccharomyces cerevisiae co-crystallized with an antibody Fv fragment. , 2000, Structure.

[4]  Akhil B. Vaidya,et al.  A Mechanism for the Synergistic Antimalarial Action of Atovaquone and Proguanil , 1999, Antimicrobial Agents and Chemotherapy.

[5]  M. Fry,et al.  Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4'-chlorophenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone (566C80). , 1992, Biochemical pharmacology.

[6]  Alexei Vagin,et al.  Molecular replacement with MOLREP. , 2010, Acta crystallographica. Section D, Biological crystallography.

[7]  F. Gamo,et al.  Exploration of 4(1H)-pyridones as a novel family of potent antimalarial inhibitors of the plasmodial cytochrome bc1. , 2012, Future medicinal chemistry.

[8]  Garib N. Murshudov,et al.  JLigand: a graphical tool for the CCP4 template-restraint library , 2012, Acta crystallographica. Section D, Biological crystallography.

[9]  M. Rossmann,et al.  Antibody-induced uncoating of human rhinovirus B14 , 2017, Proceedings of the National Academy of Sciences.

[10]  S. Rawson,et al.  The changing landscape of membrane protein structural biology through developments in electron microscopy , 2016, Molecular membrane biology.

[11]  Ge-Fei Hao,et al.  Computational discovery of picomolar Q(o) site inhibitors of cytochrome bc1 complex. , 2012, Journal of the American Chemical Society.

[12]  D. Julius,et al.  TRPV1 structures in nanodiscs reveal mechanisms of ligand and lipid action , 2016, Nature.

[13]  S. Antonyuk,et al.  Antimalarial 4(1H)-pyridones bind to the Qi site of cytochrome bc1 , 2015, Proceedings of the National Academy of Sciences.

[14]  L. Esser,et al.  Surface-modulated motion switch: Capture and release of iron–sulfur protein in the cytochrome bc1 complex , 2006, Proceedings of the National Academy of Sciences.

[15]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[16]  Peter D Gibbons,et al.  2-Pyridylquinolone antimalarials with improved antimalarial activity and physicochemical properties , 2015 .

[17]  E. Carpenter,et al.  Overcoming the challenges of membrane protein crystallography , 2008, Current opinion in structural biology.

[18]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[19]  G. Nixon,et al.  Targeting the mitochondrial electron transport chain of Plasmodium falciparum: new strategies towards the development of improved antimalarials for the elimination era. , 2013, Future medicinal chemistry.

[20]  Maojun Yang,et al.  Structure of Mammalian Respiratory Supercomplex I1III2IV1 , 2016, Cell.

[21]  Archie L. Smith.  [13] Preparation, properties, and conditions for assay of mitochondria: Slaughterhouse material, small-scale , 1967 .

[22]  D. Agard,et al.  MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy , 2017, Nature Methods.

[23]  U. H. Danielson,et al.  Biophysics in drug discovery: impact, challenges and opportunities , 2016, Nature Reviews Drug Discovery.

[24]  P. Mastroiacovo,et al.  The global burden of congenital toxoplasmosis: a systematic review. , 2013, Bulletin of the World Health Organization.

[25]  L. Yu,et al.  Soluble cytochrome b-c1 complex and the reconstitution of succinate-cytochrome c reductase. , 1974, The Journal of biological chemistry.

[26]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[27]  David J. Fleet,et al.  cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination , 2017, Nature Methods.

[28]  H. Schägger,et al.  Isolation of the eleven protein subunits of the bc1 complex from beef heart. , 1986, Methods in enzymology.

[29]  L. Esser,et al.  Structural basis for the quinone reduction in the bc1 complex: a comparative analysis of crystal structures of mitochondrial cytochrome bc1 with bound substrate and inhibitors at the Qi site. , 2003, Biochemistry.

[30]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[31]  Sjors H.W. Scheres,et al.  RELION: Implementation of a Bayesian approach to cryo-EM structure determination , 2012, Journal of structural biology.

[32]  F. Daldal,et al.  X-Ray Structure of Rhodobacter Capsulatus Cytochrome bc1: Comparison with its Mitochondrial and Chloroplast Counterparts , 2004, Photosynthesis Research.

[33]  Peter D Gibbons,et al.  Identification, Design and Biological Evaluation of Bisaryl Quinolones Targeting Plasmodium falciparum Type II NADH:Quinone Oxidoreductase (PfNDH2) , 2012, Journal of medicinal chemistry.

[34]  C. Fishwick,et al.  The potential use of single-particle electron microscopy as a tool for structure-based inhibitor design , 2017, Acta crystallographica. Section D, Structural biology.

[35]  J. Hemingway,et al.  Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria , 2012, Proceedings of the National Academy of Sciences.

[36]  Shaoxia Chen,et al.  Prevention of overfitting in cryo-EM structure determination , 2012, Nature Methods.

[37]  D. Veesler,et al.  CryoEM structure of a prokaryotic cyclic nucleotide-gated ion channel , 2017, Proceedings of the National Academy of Sciences.

[38]  Philip R. Evans,et al.  How good are my data and what is the resolution? , 2013, Acta crystallographica. Section D, Biological crystallography.

[39]  Garib N. Murshudov,et al.  Conformation-independent structural comparison of macromolecules with ProSMART , 2014, Acta crystallographica. Section D, Biological crystallography.

[40]  L. Shultz,et al.  Improved Murine Model of Malaria Using Plasmodium falciparum Competent Strains and Non-Myelodepleted NOD-scid IL2Rγnull Mice Engrafted with Human Erythrocytes , 2009, Antimicrobial Agents and Chemotherapy.

[41]  F. Daldal,et al.  Ascochlorin is a novel, specific inhibitor of the mitochondrial cytochrome bc1 complex. , 2010, Biochimica et biophysica acta.

[42]  Maojun Yang,et al.  Architecture of Human Mitochondrial Respiratory Megacomplex I2III2IV2 , 2017, Cell.

[43]  Kai Zhang,et al.  Gctf: Real-time CTF determination and correction , 2015, bioRxiv.

[44]  Organização Mundial de Saúde,et al.  World malaria report 2011 , 2011 .

[45]  Sung-Hou Kim,et al.  Electron transfer by domain movement in cytochrome bc1 , 1998, Nature.

[46]  Sozanne R. Solmaz,et al.  Structure of Complex III with Bound Cytochrome c in Reduced State and Definition of a Minimal Core Interface for Electron Transfer* , 2008, Journal of Biological Chemistry.

[47]  L. Esser,et al.  Structural analysis of cytochrome bc1 complexes: implications to the mechanism of function. , 2013, Biochimica et biophysica acta.

[48]  T. A. Link,et al.  Complete structure of the 11-subunit bovine mitochondrial cytochrome bc1 complex. , 1998, Science.

[49]  P. A. Pearson,et al.  Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients. , 1999, Ophthalmology.

[50]  Wei-Chun Kao,et al.  Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action , 2014, Nature Communications.

[51]  Owen Johnson,et al.  iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM , 2011, Acta crystallographica. Section D, Biological crystallography.

[52]  R. Yolken,et al.  Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis , 2012, Proceedings of the National Academy of Sciences.

[53]  L. Esser,et al.  Crystallographic studies of quinol oxidation site inhibitors: a modified classification of inhibitors for the cytochrome bc(1) complex. , 2004, Journal of molecular biology.

[54]  Joanne M. Morrisey,et al.  Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum , 2007, Nature.

[55]  J Deisenhofer,et al.  Crystal structure of the cytochrome bc1 complex from bovine heart mitochondria. , 1997, Science.

[56]  Leonardo G. Trabuco,et al.  Molecular dynamics flexible fitting: a practical guide to combine cryo-electron microscopy and X-ray crystallography. , 2009, Methods.

[57]  A. Bartesaghi,et al.  2.3 Å resolution cryo-EM structure of human p97 and mechanism of allosteric inhibition , 2016, Science.

[58]  L. Esser,et al.  Inhibitor-complexed Structures of the Cytochrome bc1 from the Photosynthetic Bacterium Rhodobacter sphaeroides* , 2008, Journal of Biological Chemistry.

[59]  J. Boothroyd,et al.  Characterization of cytochrome b from Toxoplasma gondii and Q(o) domain mutations as a mechanism of atovaquone-resistance. , 2000, Molecular and biochemical parasitology.

[60]  B. Trumpower,et al.  Purification of a three-subunit ubiquinol-cytochrome c oxidoreductase complex from Paracoccus denitrificans. , 1986, The Journal of biological chemistry.

[61]  P. Mitchell,et al.  Possible molecular mechanisms of the protonmotive function of cytochrome systems. , 1976, Journal of theoretical biology.

[62]  E. Berry,et al.  Binding of the respiratory chain inhibitor antimycin to the mitochondrial bc1 complex: a new crystal structure reveals an altered intramolecular hydrogen-bonding pattern. , 2005, Journal of molecular biology.

[63]  G. Shanks,et al.  Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.